Recent evidence suggests that mesenchymal stem cells (MSC) selectively home to tumors, where they contribute to the formation of tumor-associated stroma. This effect can be opposed by genetically modifying MSC to produce high levels of anti-cancer agents that blunt tumor growth kinetics and inhibit the growth of tumors in situ. In this review article, we describe the biological properties of MSC within the tumor microenvironment and discuss the potential use of MSC and other bone marrow-derived cell populations as delivery vehicles for antitumor proteins.
Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Publishing Authors By Initials
Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Journal Published:
PUBLICATION TYPE: Review
Journal: International journal of hematology
VOLUME: 86
Page Numbers: 8-16
Journal Abbreviation: Int. J. Hematol.
ISSN: 0925-5710
DAY: 27
MONTH: Jul
YEAR: 2007
Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9111627
Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Keywords Mesh Terms:
KEYWORDS: Neoplasms
MESH TERMS: therapy
Chemical & Substance for Abstract: Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.
AFFILIATION: Department of Pediatrics, The Ohio State University and Center for Childhood Cancer, Columbus Children's Research Institute, Columbus, OH, USA.
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Int J Hematol
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles Related Publications